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تصلاخلا:  
فذهلا  :ىح ىيًصح ِذه تسارذنا نقيقحخه ٍي رود واسجلأا ةداضًنا تيحاذنا شيذسكوزيبهن  يف تيقرذنا ةذغنا ثاَىيزهب اهخقلاعو تيقرذنا ةذغناتيضازيأ 
 ةذغهن تيحاذنا تعاًُناتيقرذنا .فذهنا ساجَا ىح تيحلآا ثاىطخنا تطساىب و  
تيجهىملا :ل وذناب تصاخ ثادذحي صايق ( 09  ) ةذغنا ثاَىيزه ًٍضخح يخناو ,يًيهعخنا رذصنا ىفشخسي يف ثاَىيزهنا شكزي ٌوداحزي ًٍي صخش
 تيقرذناواسجلأاو  . تيحاذنا تيقرذنا ةذغنا شيذيسكوزيبن ةداضًنا  
جئاتىلا :أظثزه تيقرذنا ةذغنا ٍي ةسزفًنا ثاَىيزهنا ثلاذعي ٍيب تقلاع دىجو وذع جئاخُنا ونا تيياخُنا ةذغ واسجلأاب  ةذغنا شيذيسكوزيبن ةداضًنا
.تيحاذنا تيقرذنا 
جاتىتسلااثا  :جُيب ِذه تسارذنا ٌأ ن حضاو رود ذجىي لاواسجلأ ةداضًنا شيذيسكوزيبهنتيقرذنا ةذغنا  فئاظو ىهع تيحاذنانا ثاَىيزه مبق ٍي ةسزفًنا
.تيقرذنا ةذغنا 
ثايصىتلا  :  عىضىًنا اذه لىح تعسىي ثاسارذب وايقنا لاًعخسابةذيذع ثاُيع   ون تيعاُي ثارابخخا ءازجأ داًخعاهيُيحور مكشب و صيخشخ.  
Abstract: 
Objectives: This Study was designed to investigate the role of the auto antibodiesagainst  thyroid peroxidise 
(TPO-Abs) and thyroid Hormones (T3, T4, TSH)  in pathogenesis of Autoimmune Thyroid Disease (AITD). 
Methodology: Blood parameters of (90) individual  who were attended to hormonal centre at AlSadder Medical 
City, in the period from January 2013 to June 2013 were measured, which includes Ttriiodothyronine (T3), 
Thyroxine or Tetraiodothyronine (T4), Thyroid Stimulating Hormone (TSH) and auto antibodies  of thyroid 
peroxidise (TPO-Abs), the biostatic use difference between the maximum and minimum values (range). 
Results: the search results showed no significant increase in the rate of thyroid hormones (T3, T4, TSH) (p>0.2). 
Conclusion: The auto antibodies  of thyroid peroxidise has no rule in function of thyroid hormones. 
Recommendations: Further studies with numerous sample are needed. 
Keywords: Autoimmune Thyroid Disease (AITD), thyroid hormones (T3, T4, TSH), anti-thyroid peroxidise-Abs 
(TPO-Abs). 
 
INTRODUCTION 
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Autoimmune thyroid diseases (AITDs), including Graves' disease (GD) and Hashimoto's 
thyroiditis (HT), are caused by immune response to self-thyroid antigens and affect 
approximately (2–5%) of the general population. Genetic susceptibility in combination with 
external factors, such as smoking, viral/bacterial infection, and chemicals, is believed to initiate 
the autoimmune response against thyroid antigens 
(1)
.Autoantibodies to thyroid peroxidase 
(TPO) are reflections of thyroid disease rather than causative agents. Hence, such thyroid 
autoantibodies may develop before the onset of clinical (AITD) and have been long known to 
increase the risk of developing clinical (AITD). Indeed, up to (50%) of the siblings of patients 
with (AITD) are thyroid antibody positive in contrast to (~15%) in the general population
(2) 
.Thyroxine ( T4 ) and triiodothyronine ( T3 ) are vital for normal growth and development and 
control essential functions , such as energy, metabolism and protein synthesis  while reverse 
triiodothyronine ( rT3 ) is inactive hormone
(3)
. TSH (Thyroid Stimulating Hormone) is also 
known as thyrotropin. which increases thyroid secretion
(4)
. The secretion of TSH is controlled 
by: 
- Circulating concentration of thyroid hormones. 
- Thyrotrophin-Relasing Hormones (TRH)(5). 
 
The metabolic manifestations of the thyroid disease related to either excessive or 
inadequate production of thyroid hormones (hyperthyroidism and hypothyroidism, 
respectively)
(6)
. 
Blood tests: Usually includes measurement of: serum T4 and T3, resin T3 uptake, T4 
binding ratio, free T4 index, TSH, and antithyroid antibodies level
(7)
. 
Objectives: This Study was designed to investigate the role of the auto antibodiesagainst  
thyroid peroxidise (TPO-Abs) and thyroid Hormones (T3, T4, TSH)  in pathogenesis of 
Autoimmune Thyroid Disease (AITD). 
 
METHODS: 
Perverse study was performed on (90) individual who were attended to AlSadder 
Medical City, in the period from January 2013 to June 2013.Three study groups were 
investigated which included: 
 
1. First group: Thirty patients with Hypothyroidism  of both sexes (26 female and 4 male)  
their ages>15 years old. 
2. Second group: Thirty patients with Hyperthyroidism of both sexes (20 female and 10 
male)  their ages >15 years old. 
3. Third group: Thirty people as a control group who had no history or clinical evidence of  
any acute and chronic disease. 
 
All samplewere kept for few minutes to allow the clotting form. Serum was separated 
by centrifugation at (1500) rpm and divided into small (200 μl ) aliquots and kept at 
deep freeze (-20 C˚) to be used for different investigations by us ELISA technique. 
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RESULTS: 
Table(1) Correlation between Anti-Thyroidal peroxidase Aband Thyroid hormones 
(T3,T4, and TSH) among HT patients. 
 Anti-TPO-Abs 
Variable Rang P value 
T3 0.011 0.954 N.S 
T4 0.021 0.914 N.S 
TSH -0.045 0.379 N.S 
This Table showed that there were no significant correlation between anti-TPO-Ab and Thyroid 
hormones (T3,T4, and TSH)(p=0.954, 0.914, 0.379 respectively ) in HT patients. 
 
Table(2) Correlation between Anti-Thyroidal peroxidase Ab and Thyroid hormones 
(T3,T4, and TSH) among GD patients. 
 Anti-TPO-Abs 
Variable Rang P value 
T3 -0.013 0.947 N.S 
T4 0.051 0.790 N.S 
TSH 0.232 0.218 N.S 
This Table showed that there were no significant correlation between anti-TPO-Ab and Thyroid 
hormones (T3,T4, and TSH)(p=0.947, 0.790, 0.790 respectively ) in GD patients. 
 
Table(3) Relation between Anti-Thyroidal peroxidase Ab and Thyroid hormones (T3,T4, 
and TSH),  among control group. 
 Anti-TPO-Abs 
Variable Rang P value 
T3 1.3720 
 
0.233 N.S 
T4 1.1144 0.224 N.S 
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TSH 1.3600 
 
0.204 N.S 
This Table showed that there were no significant correlation between anti-TPO-Ab and Thyroid 
hormones (T3,T4, and TSH)(p=0.233, 0.224, 0.204 respectively ) among control group. 
 
DISCUSSION:  
In recent years, the pathogenic role and the diagnostic value of anti-TPO antibody have 
been evaluated in (AITD) patients. Most of studies show detection of anti-TPO antibody has 
high specificity for (AITD) and the presence of anti-TPO antibody has been noted in early 
(AITD)
(9)
. Their mean age distribution were in agreement with many studies that have been 
done before 
(8)
. 
Moreover, 
(10)
 shows the appearance of anti-TPO antibody in the circulation may occur 
at several years before (AITD) onset and anti-TPO antibody represents a marker of future 
(AITD). The importance of anti-TPO evokes in diagnosis of (AITD). However, present data 
represented these no relationships between anti-TPO antibodies and Thyroid hormones (T3,T4, 
and TSH ). These findings were compatible to the results reported by (11) who found that 
proportional correlation was noticed between anti-TPO and (AITD) marker particularly TSH. 
The normal levels of T3 is below 1.6 nm/l and for T4 is between (4.2-11.0 nm/l) ,while, the 
normal levels of TSH is 0.25 to 5 
(12) . 
Serum TSH concentration are considered the most 
reliable indicator of thyroid function abnormalities, and TSH analysis stands as the primary 
means of study thyroid function. However, small changes in T4 concentration will provoke 
very large changes in serum TSH 
(13)
. Because the pathogenesis of (AITD). 
It is still not well clear, many studies in relation with it. Therefore, in this study we have 
analysed and examined the role of an increase of anti-TPO-Ab serum level in function of 
thyroid hormones. However, the current findings concerning there was any increase in T3, T4 
and TSH serum levels depending on concentration of anti-TPO-Ab. However, These findings 
were compatible to the results reported by 
(14)
 who found that strong correlation was noticed 
between anti-TPO and AITD marker particularly TSH. Our study was correspondence with 
previous studies
(15)
 they mentioned, there are no relationship between Serum TSH 
concentration and anti-TPO-Ab also no association between thyroid hormones (T3, T4) and 
anti-TPO-Ab. This was expected 
(16)
. 
 
CONCLUSION: 
There areno relationship between Serum (T3, T4, and TSH ) concentration and anti-TPO-Ab 
RECOMMENDATIONS: 
1.Use more than one diagnostic test for diagnosis of AITD. 
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2.Further studies with large samples are needed. 
3.Anti-Thyroid Peroxidase Antibodies (IgG)a good serological marker for diagnosis of  (AITD) 
and to be used routinely. 
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